Peptide compounds and methods of treating diseases thereof
By using 5 or 7 amino acids composed of specific amino acid sequences to isolate the peptides and activate the Akt signaling system, the problem of difficulty in reducing cellular and immune stress responses in the prior art is solved, and effective reduction of inflammatory and autoimmune diseases is achieved.
CN119708141APending Publication Date: 2025-03-28IMMUNE PHARMACEUTICALS LTD
25 Cites 0 Cited by
Patent Information
- Application Number
- CN202411888869.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2020-01-15
- Filing Date
- 2021-01-14
- Publication Date
- 2025-03-28
AI Technical Summary
Technical Problem
The prior art is difficult to effectively weaken the cellular and immune stress responses in normal tissues, resulting in the difficulty in reducing the severity of inflammatory and autoimmune diseases.
Method used
An isolated peptide consisting of 5 or 7 amino acids, consisting of a specific amino acid sequence, is provided to reduce dexamethasone-induced spleen and/or thymus weight loss, protecting cells by activating the Akt signaling system.
Benefits of technology
This peptide can significantly reduce dexamethasone-induced spleen and thymus weight loss and minimize dexamethasone-induced spleen and thymus cell count, providing a specific, safe and effective way to reduce the severity of inflammatory and autoimmune diseases.
✦ Generated by Eureka AI based on patent content.
Abstract
The present application provides peptide compounds and methods of treating diseases thereof. Isolated peptides are capable of reducing the amount of dexamethasone-induced weight loss of the spleen and / or thymus in a mouse. Use of the plurality of isolated peptides for the treatment of inflammatory or degenerative diseases.
Need to check novelty before this filing date? Find Prior Art